Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 3

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Conditions

Arthritis, Rheumatoid 8Psoriasis 7Lymphoma, Follicular 4Leukemia 4Myelodysplastic Syndromes 3Asthma 3Vasculitis 2Respiratory Distress Syndrome 2Recurrence 2Pneumonia 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Inflammation 2Granulomatosis with Polyangiitis 2Bronchiolitis Obliterans 2Arthritis, Psoriatic 2Arthritis, Juvenile 2Wilms Tumor 1Uveitis 1Temporomandibular Joint Disorders 1Spondylitis, Ankylosing 1Spondylarthritis 1Pruritus 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Plaque, Amyloid 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms 1Metabolic Syndrome 1

Interventions

Etanercept 3Fluticasone-Salmeterol Drug Combination 2Fluticasone 2Budesonide 2Beclomethasone 2laninamivir 1Lysine Acetyltransferase 5 1Helium 1Formoterol Fumarate 1Escitalopram 1Cari-D-Tect 1CS 8958 1Budesonide, Formoterol Fumarate Drug Combination 1Blood Specimen Collection 1Azithromycin 1Amoxicillin-Potassium Clavulanate Combination 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Asthma × Etanercept × Clear all
NCT00001893 2017-07-02

Study of TNFR:Fc (Enbrel) in the Treatment of Asthma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
150 enrolled

Asthma

NCT00141791 2009-08-07

Study Evaluating Etanercept in Moderate to Severe Asthma

Wyeth is now a wholly owned subsidiary of Pfizer

Phase 2 Completed
120 enrolled

Asthma

NCT00276029 2006-05-04

TNF Alpha in Refractory Asthma

University Hospitals, Leicester

Phase NA Completed
10 enrolled

Asthma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡